TIVC vs. HSDT, NUWE, NDRA, NBSE, CANOQ, INM, BJDX, ATNF, LSDI, and NMRD
Should you be buying Tivic Health Systems stock or one of its competitors? The main competitors of Tivic Health Systems include Helius Medical Technologies (HSDT), Nuwellis (NUWE), ENDRA Life Sciences (NDRA), NeuBase Therapeutics (NBSE), Cano Health (CANOQ), InMed Pharmaceuticals (INM), Bluejay Diagnostics (BJDX), 180 Life Sciences (ATNF), Lucy Scientific Discovery (LSDI), and Nemaura Medical (NMRD). These companies are all part of the "medical" sector.
Helius Medical Technologies (NASDAQ:HSDT) and Tivic Health Systems (NASDAQ:TIVC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, community ranking, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.
Helius Medical Technologies received 20 more outperform votes than Tivic Health Systems when rated by MarketBeat users.
Tivic Health Systems has a net margin of -701.02% compared to Tivic Health Systems' net margin of -1,328.14%. Helius Medical Technologies' return on equity of -186.19% beat Tivic Health Systems' return on equity.
Helius Medical Technologies has a beta of 1.6, suggesting that its stock price is 60% more volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 2.83, suggesting that its stock price is 183% more volatile than the S&P 500.
In the previous week, Helius Medical Technologies had 5 more articles in the media than Tivic Health Systems. MarketBeat recorded 11 mentions for Helius Medical Technologies and 6 mentions for Tivic Health Systems. Tivic Health Systems' average media sentiment score of 0.51 beat Helius Medical Technologies' score of 0.38 indicating that Helius Medical Technologies is being referred to more favorably in the media.
18.6% of Helius Medical Technologies shares are owned by institutional investors. Comparatively, 4.3% of Tivic Health Systems shares are owned by institutional investors. 7.3% of Helius Medical Technologies shares are owned by insiders. Comparatively, 2.7% of Tivic Health Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Tivic Health Systems has higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than Tivic Health Systems, indicating that it is currently the more affordable of the two stocks.
Helius Medical Technologies presently has a consensus target price of $24.00, suggesting a potential upside of 1,478.95%. Given Tivic Health Systems' higher probable upside, research analysts clearly believe Helius Medical Technologies is more favorable than Tivic Health Systems.
Summary
Helius Medical Technologies beats Tivic Health Systems on 10 of the 16 factors compared between the two stocks.
Get Tivic Health Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for TIVC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TIVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Tivic Health Systems Competitors List
Related Companies and Tools
